Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2025-12-25 @ 7:53 PM
Study NCT ID:
NCT07256392
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Sponsor:
Celldex Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-20
First Submit QC Date:
None
Study First Post Date:
2025-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-22
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL